HABP

AcronymDefinition
HABPHospital-Acquired Bacterial Pneumonia
HABPHyaluronic Acid-Binding Protein
HABPHigh Availability Business Partner (IBM)
HABPHarmful Algal Bloom Programme (Intergovernmental Oceanographic Commission; UNESCO)
HABPHigh Arterial Blood Pressure
References in periodicals archive ?
A cross-sectional study designed from January 2013 till January 2014 included all 16 patients admitted to the ICU with HABP requiring mechanical ventilation for at least 48 hours in a general hospital in south of Iran were included.
Resistance of gram negative bacteria in hospital acquired pneumonia: a prospective study
To further identify the role of HA in ozone-induced inflammasome activation, we pretreated WT animals with HABP, which reduces the level of HA in the lungs (Garantziotis et al.
Hyaluronan activation of the Nlrp3 inflammasome contributes to the development of airway hyperresponsiveness
A second non-MAF HABP has also been demonstrated by immunohistochemistry on Microciona cell surfaces.
Hyaluronic Acid: A Component of the Aggregation Factor Secreted by the Marine Sponge, Microciona prolifera
A total of 870 hospitalized adult patients with HABP or VABP were randomized and received trial medications comparing AVYCAZ 2.5 g (ceftazidime 2 grams and avibactam 0.5 grams) intravenously every eight hours to meropenem 1 gram intravenously every eight hours, said the company.
Allergan plc passes US FDA's expanded approval for sNDA AVYCAZ to include HABP/VABP in adults
This prospective, randomised, double-blind, multicenter, non-inferiority, Phase 3 study assessed the safety and efficacy of Zerbaxa compared with meropenem in 726 adult patients diagnosed with either ventilated HABP or VABP requiring intravenous antibiotic therapy.
US Merck Says Zerbaxa Met Primary Endpoints of Non-Inferiority Compared to Meropenem in Pivotal Phase 3 Study of Adult Patients with Hospital-Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia
M2 EQUITYBITES-February 2, 2018-Allergan plc wins US FDA's approval for supplemental sNDA for the expanded use of AVYCAZ for HABP &VABP
Allergan plc wins US FDA's approval for supplemental sNDA for the expanded use of AVYCAZ for HABP &VABP
The company said the clinical trial is designed to assess the intrapulmonary penetration and pharmacokinetics of ZOLYD to support future development for US patients with hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) infections, with a combined mortality rate of up to 33%.
Zavante Therapeutics partners with NIAID to assess ZOLYD for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia
Drug development company ICON plc (NasdaqGS:ICLR) said on Monday that it has won a US Food & Drug Administration (FDA) project to validate three Patient Reported Outcomes (PRO) instruments that will measure clinical endpoints in antibacterial drug trials of therapies for Acute Bacterial Skin and Skin Structure Infections (ABSSSI), Community-Acquired Bacterial Pneumonia (CABP) and Hospital-Acquired Bacterial Pneumonia (HABP).
ICON partners with US FDA to validate patient-reported outcome endpoints for antibacterial drug trials
M2 PHARMA-February 2, 2018-Allergan plc wins US FDA's approval for supplemental sNDA for the expanded use of AVYCAZ for HABP &VABP
Allergan plc wins US FDA's approval for supplemental sNDA for the expanded use of AVYCAZ for HABP &VABP
The firm requested Qualified Infectious Diseases Product designation for Iclaprim for two serious and life threatening infections, HABP and acute bacterial skin and skin structure infections.
Motif Bio receives Qualified Infectious Diseases Product designation for iclaprim
Acronyms browser ?
Full browser ?